Creating Sky High Level Interest in Rare Diseases
Discussions with multiple pharma companies confirmed the need to better understand physicians’ knowledge about ...
Virtual Reality in Pharmaceutical Marketing—The Target’s Point of View
I am your optimal target customer. As an academically trained internist and cardiologist, NIH trained ...
Key Principles for Sales and Marketing Messages in the Face of Reduced Access to Oncologists
Oncology treatment breakthroughs provide patients and oncologists with an increased array of innovative treatment ...
What Do Doctors Want?
There’s probably no word more ubiquitous in the healthcare industry these days than “trust.” ...
Trump’s Love/Hate Relationship with Pharma
President Trump’s love/hate relationship with pharma will undoubtedly affect the care of my patients ...
Will the 21st Century Cures Act Lead to New Cures?
Late last year, the 21st Century Cures Act was signed into law after it ...
Multichannel Marketing with Physician-Level Data
Pioneering Philadelphia retailer John Wanamaker is often quoted as saying, “Half the money I ...
An Enormous Wasted Opportunity—Packaging
I can make almost any patient take their medication as directed. It isn’t hard, ...
Lessons From The Presidential Election
The recent presidential election provided a fine example of how the analytics community can ...
The Delay of Adapting Innovation in Clinical Practice
The medical world is innovating at an ever-increasing speed, especially here in the U.S. ...
Pharmaceutical Control is Shifting Again—Now it’s Health Systems in Charge!
My medical career has moved in line with the shift in prescription control. As ...
Eyes on the Bottom Line
Healthcare costs affect all of us, both personally and professionally. With the steady drumbeat ...
The Stars for Healthcare Partnerships are Aligning!
It doesn’t take a marketing and sales genius to know that your bottom line ...